Innobon
Cheonan
About Innobon
Innobon develops synthetic bone graft materials for the treatment of bone defects and bone reconstruction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $350.2K
- Funding stage: Seed
- Last round: Seed (Apr 2019)
- Website: inobone.com
- Phone: +82 041 906 5666
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/innobon-177608 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.